☆ 4.6 Article

Study on the effect of 40 Hz non-invasive light therapy system. A protocol for a randomized, double-blinded, placebo-controlled clinical trial

FRONTIERS IN AGING NEUROSCIENCE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Multidisciplinary Sciences

FDA approves Alzheimer’s drug lecanemab amid safety concerns

Sara Reardon

NATURE (2023)

添加到收藏夹

Article Medicine, General & Internal

Lecanemab in Early Alzheimer's Disease

Christopher H. van Dyck et al.

Summary: Lecanemab, a humanized monoclonal antibody, reduced amyloid markers and showed improvement in cognition and function in early Alzheimer's disease patients. However, it also resulted in adverse events. Longer trials are needed to determine its efficacy and safety in early Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Neurosciences

Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light

Mikkel Pejstrup Agger et al.

Summary: This study presents a novel method of 40 Hz entrainment using invisible spectral flicker (ISF) and shows that ISF has a higher signal-to-noise ratio in 40 Hz neural activity compared to continuous light (CON) and 40 Hz stroboscopic light (STROBE). This method could be a new treatment option for Alzheimer's disease and could reduce discomfort for patients.

JOURNAL OF ALZHEIMERS DISEASE (2022)

添加到收藏夹

Article Medicine, General & Internal

Lecanemab for Alzheimer's disease: tempering hype and hope

The Lancet

LANCET (2022)

添加到收藏夹

Article Clinical Neurology

Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice

P. M. Cogswell et al.

Summary: Monoclonal antibodies are a new therapy for Alzheimer's disease that require brain MR imaging for assessment and monitoring of amyloid-related imaging abnormalities. These abnormalities result from treatment-related loss of vascular integrity and can manifest as edema or effusion, or as hemorrhage. With increasing availability of these antibodies, neuroradiologists must become familiar with the imaging appearance, select appropriate imaging protocols, and report findings. Standardized imaging and reporting are important for determining patient management and eligibility for continued monoclonal antibody dosing.

AMERICAN JOURNAL OF NEURORADIOLOGY (2022)

添加到收藏夹

Article Neurosciences

Sensory-Evoked 40-Hz Gamma Oscillation Improves Sleep and Daily Living Activities in Alzheimer's Disease Patients

Aylin Cimenser et al.

Summary: The study found that 40 Hz sensory stimulation therapy can benefit AD patients by reducing nighttime activity and maintaining functional abilities.

FRONTIERS IN SYSTEMS NEUROSCIENCE (2021)

添加到收藏夹

Article Clinical Neurology

Alzheimer's disease drug development pipeline: 2021

Jeffrey Cummings et al.

Summary: Overall, the study highlights the urgent need for new treatments for Alzheimer's disease, and shows that a diverse range of drugs targeting the biology of AD are being explored in clinical trials. Biomedical biomarkers are also being increasingly used in these trials to assess effectiveness.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)

添加到收藏夹

Article Clinical Neurology

Event marker compliance in actigraphy

Ivan C. Zibrandtsen et al.

JOURNAL OF SLEEP RESEARCH (2020)

添加到收藏夹

Review Neurosciences

Gamma Entrainment: Impact on Neurocircuits, Glia, and Therapeutic Opportunities

Chinnakkaruppan Adaikkan et al.

TRENDS IN NEUROSCIENCES (2020)

添加到收藏夹

Article Clinical Neurology

Sensory‐evoked gamma frequency oscillations in Alzheimer’s disease patients: Biomarker and therapeutic applications

Mihaly Hajos et al.

Alzheimers & Dementia (2020)

添加到收藏夹

Proceedings Paper Biochemistry & Molecular Biology

40 Hz Invisible Spectral Flicker and its Potential Use in Alzheimer's Light Therapy Treatment

Marcus S. Carstensen et al.

MECHANISMS OF PHOTOBIOMODULATION THERAPY XV (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition

Anthony J. Martorell et al.

CELL (2019)

添加到收藏夹

Article Neurosciences

Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection

Chinnakkaruppan Adaikkan et al.

NEURON (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Justin M. Long et al.

CELL (2019)

添加到收藏夹

Article Clinical Neurology

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Emma Nichols et al.

LANCET NEUROLOGY (2019)

添加到收藏夹

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

添加到收藏夹

Review Neurosciences

Gamma Band Neural Stimulation in Humans and the Promise of a New Modality to Prevent and Treat Alzheimer's Disease

Barry McDermott et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

添加到收藏夹

Article Biochemical Research Methods

Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load

Annabelle C. Singer et al.

NATURE PROTOCOLS (2018)

添加到收藏夹

Article Multidisciplinary Sciences

A High-Speed SSVEP-Based BCI Using Dry EEG Electrodes

Xiao Xing et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Systematic Review on Resting-State EEG for Alzheimer's Disease Diagnosis and Progression Assessment

Raymundo Cassani et al.

DISEASE MARKERS (2018)

添加到收藏夹

Article Neurosciences

Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study

Amy Clements-Cortes et al.

JOURNAL OF ALZHEIMERS DISEASE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Gamma frequency entrainment attenuates amyloid load and modifies microglia

Hannah F. Iaccarino et al.

NATURE (2016)

添加到收藏夹

Article Neuroimaging

The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI

Jeannine Skinner et al.

BRAIN IMAGING AND BEHAVIOR (2012)

添加到收藏夹

Article Clinical Neurology

Methodology of photic stimulation revisited: Updated European algorithm for visual stimulation in the EEG laboratory

Dorothee Kasteleijn-Nolst Trenite et al.

EPILEPSIA (2012)

添加到收藏夹

Article Clinical Neurology

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup

Reisa A. Sperling et al.

ALZHEIMERS & DEMENTIA (2011)

添加到收藏夹

Article Neurosciences

Potentiation of Gamma Oscillatory Activity through Repetitive Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex

Mera S. Barr et al.

NEUROPSYCHOPHARMACOLOGY (2009)

添加到收藏夹

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

添加到收藏夹

Article Neurosciences

Human EEG responses to 1-100 Hz flicker: resonance phenomena in visual cortex and their potential correlation to cognitive phenomena

CS Herrmann

EXPERIMENTAL BRAIN RESEARCH (2001)

添加到收藏夹

Article Medicine, General & Internal

Statistics Notes - Blinding in clinical trials and other studies

SJ Day et al.

BRITISH MEDICAL JOURNAL (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.